HIV感染对代谢功能障碍相关脂肪性肝病退伍军人肝脏与心血管结局的影响
基于美国退伍军人事务部2010至2022年全国数据,构建倾向评分匹配队列,比较920例合并HIV的MASLD患者与920例无HIV的MASLD患者。合并HIV者主要不良心血管事件发生率更高(5.18 vs 4.48每100人年,P=0.03),5年总生存率显著更低且未接受抗逆转录病毒治疗者更低;肝硬化与肝细胞癌发生率无差异。
要点
- 合并HIV的MASLD患者主要不良心血管事件发生率高于无HIV者(5.18 vs 4.48每100人年,P=0.03)。
- 合并HIV的MASLD患者5年总生存率显著低于无HIV者,未接受抗逆转录病毒治疗者更低。
- 合并HIV与无HIV的MASLD患者肝硬化及肝细胞癌发生率相似。
核心结论
- 在美国退伍军人MASLD患者中,合并HIV感染、尤其未接受抗逆转录病毒治疗,与心血管疾病风险增加和总生存率降低相关。
- 未观察到肝硬化或肝细胞癌风险差异。
研究设计与样本
- 利用美国退伍军人事务部2010至2022年全国数据,构建倾向评分匹配队列,比较合并与不合并HIV的MASLD患者。
- 倾向匹配队列包括920例合并HIV的MASLD患者和920例不合并HIV的MASLD患者,两组人口学特征和合并症相似。
主要发现
- 与不合并HIV的MASLD患者相比,合并HIV的MASLD患者肝硬化和肝细胞癌发生率相似。
- 与不合并HIV的MASLD患者相比,合并HIV的MASLD患者主要不良心血管事件发生率更高(5.18 vs 4.48每100人年,P=0.03)。
- 合并HIV的MASLD患者5年总生存率显著更低,未接受抗逆转录病毒治疗者更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Hepatic steatosis is highly prevalent in people living with HIV. It remains unclear whether HIV in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with greater risks of liver disease progression and cardiovascular disease (CVD). We aim to evaluate the impact of HIV infection on risks of liver and CVD outcomes among US Veterans with MASLD. METHODS: Using national Veterans Administration data from 2010 to 2022, we created a propensity score-matched cohort of MASLD patients with vs without HIV. Primary outcomes were incidence of cirrhosis and hepatocellular carcinoma (HCC) among patients with vs without HIV and patients with MASLD-HIV on antiretroviral therapy (ART) vs not on ART. Secondary outcomes included incidence of major adverse cardiovascular events and overall survival. RESULTS: The propensity-matched cohort included 920 MASLD patients with HIV and 920 MASLD patients without HIV and was similar in demographics and comorbidities. Compared with MASLD patients without HIV, incidences of cirrhosis and HCC were similar among MASLD with HIV. Compared with MASLD patients without HIV, incidence of major adverse cardiovascular event was higher among MASLD patients with HIV (5.18 vs 4.48 per 100 person-years, P = 0.03). Overall 5-year survival was significantly lower among MASLD patients with HIV and even lower among those not on ART. DISCUSSION: Among US Veterans with MASLD, concurrent HIV infection, and particularly not being on ART, is associated with greater risks of CVD and decreased overall survival. No differences in risks of cirrhosis or HCC were observed.
引用
- Wong RJ, Yang Z, Yeoh A, et al. Impact of HIV Infection on Liver and Cardiovascular Outcomes in Veterans With Metabolic Dysfunction-Associated Steatotic Liver Disease. Am J Gastroenterol. 2024. PMID: 38477465. doi:10.14309/ajg.0000000000002760
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。